5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          The aim of this study was to identify symptoms of severe intensity or very low scores for quality of life (QoL) domains in newly diagnosed outpatients with advanced cancer.

          Methods

          This multicenter cohort study from a state-wide palliative care network included adult outpatients with advanced cancer diagnosed within the preceding 8 weeks from four comprehensive cancer centers (DRKS00006162, registered on 19 May 2014). We used the Palliative Outcome Scale (POS), Hospital Anxiety and Depression Scale, and European Organization for Research and Treatment of Cancer QoL Questionnaire-C30. For each questionnaire, cut-off scores defined symptoms and QoL domains that were considered “severe” or “very low.”

          Results

          Of 3155 patients screened, 481/592 (81.3%) were analyzed (mean age 62.4; women n = 245, 50.9%). We identified 324/481 (67.4%) patients experiencing at least one severe symptom or a very low QoL domain (median 2; range 0 to 16). Role functioning ( n = 180, 37.4%), fatigue ( n = 162, 33.7%), and social functioning ( n = 126, 26.2%) were most commonly affected. QoL was very low in 89 patients (18.5%). Women experienced more anxiety symptoms, fatigue, and had lower POS scores. Patients often mentioned physical symptoms and fears of adverse events resulting from disease-modifying therapies (e.g., chemotherapy) as most relevant problems.

          Conclusions

          Already within the first 8 weeks after diagnosis, the majority of patients reported at least one severe symptom or a very low QoL domain. Gender differences were evident. The findings illustrate the value of early routine assessment of patient burden and the development of multi-professional and interdisciplinary palliative care.

          Electronic supplementary material

          The online version of this article (10.1007/s00520-020-05388-y) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: not found
          • Article: not found

          Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial.

              Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality of life. The study took place at the Princess Margaret Cancer Centre (Toronto, ON, Canada), between Dec 1, 2006, and Feb 28, 2011. 24 medical oncology clinics were cluster randomised (in a 1:1 ratio, using a computer-generated sequence, stratified by clinic size and tumour site [four lung, eight gastrointestinal, four genitourinary, six breast, two gynaecological]), to consultation and follow-up (at least monthly) by a palliative care team or to standard cancer care. Complete masking of interventions was not possible; however, patients provided written informed consent to participate in their own study group, without being informed of the existence of another group. Eligible patients had advanced cancer, European Cooperative Oncology Group performance status of 0-2, and a clinical prognosis of 6-24 months. Quality of life (Functional Assessment of Chronic Illness Therapy--Spiritual Well-Being [FACIT-Sp] scale and Quality of Life at the End of Life [QUAL-E] scale), symptom severity (Edmonton Symptom Assessment System [ESAS]), satisfaction with care (FAMCARE-P16), and problems with medical interactions (Cancer Rehabilitation Evaluation System Medical Interaction Subscale [CARES-MIS]) were measured at baseline and monthly for 4 months. The primary outcome was change score for FACIT-Sp at 3 months. Secondary endpoints included change score for FACIT-Sp at 4 months and change scores for other scales at 3 and 4 months. This trial is registered with ClinicalTrials.gov, number NCT01248624. 461 patients completed baseline measures (228 intervention, 233 control); 393 completed at least one follow-up assessment. At 3-months, there was a non-significant difference in change score for FACIT-Sp between intervention and control groups (3·56 points [95% CI -0·27 to 7·40], p=0·07), a significant difference in QUAL-E (2·25 [0·01 to 4·49], p=0·05) and FAMCARE-P16 (3·79 [1·74 to 5·85], p=0·0003), and no difference in ESAS (-1·70 [-5·26 to 1·87], p=0·33) or CARES-MIS (-0·66 [-2·25 to 0·94], p=0·40). At 4 months, there were significant differences in change scores for all outcomes except CARES-MIS. All differences favoured the intervention group. Although the difference in quality of life was non-significant at the primary endpoint, this trial shows promising findings that support early palliative care for patients with advanced cancer. Canadian Cancer Society, Ontario Ministry of Health and Long Term Care. Copyright © 2014 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                waldemar.siemens@googlemail.com
                Journal
                Support Care Cancer
                Support Care Cancer
                Supportive Care in Cancer
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0941-4355
                1433-7339
                17 March 2020
                17 March 2020
                2020
                : 28
                : 11
                : 5547-5555
                Affiliations
                [1 ]GRID grid.5963.9, Clinic for Palliative Care, Medical Center, Faculty of Medicine, , University of Freiburg, ; Robert-Koch-Str 3, 79106 Freiburg, Germany
                [2 ]GRID grid.410712.1, Department of Internal Medicine III, , University Hospital Ulm, ; Ulm, Germany
                [3 ]GRID grid.5253.1, ISNI 0000 0001 0328 4908, Internal Medicine V, Hematology/Oncology/Rheumatology, , Heidelberg University Hospital, ; Heidelberg, Germany
                [4 ]GRID grid.5253.1, ISNI 0000 0001 0328 4908, Department of Anesthesiology, Center of Pain Therapy and Palliative Care Medicine, , University Hospital Heidelberg, ; Heidelberg, Germany
                [5 ]GRID grid.5253.1, ISNI 0000 0001 0328 4908, Department of Thoracic Oncology, Member of the German Centre for Lung Research (DZL), , University Hospital Heidelberg and Translational Lung Research Center Heidelberg (TLRC-H), ; Heidelberg, Germany
                [6 ]GRID grid.411544.1, ISNI 0000 0001 0196 8249, Department of Radiooncology, Palliative Care Unit, , University Hospital of Tübingen, ; Tuebingen, Germany
                [7 ]Center for Palliative Care Hildegard, Basel, Switzerland
                Author information
                https://orcid.org/0000-0003-4238-5327
                https://orcid.org/0000-0001-9060-0285
                https://orcid.org/0000-0002-1176-3164
                Article
                5388
                10.1007/s00520-020-05388-y
                7547028
                32185557
                8080896d-cd8c-4f13-83d2-4159081561a4
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 28 January 2020
                : 26 February 2020
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001646, Robert Bosch Stiftung;
                Award ID: 11.5.1364.0055.0
                Award Recipient :
                Categories
                Original Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2020

                Oncology & Radiotherapy
                palliative care,early palliative care,quality of life,symptom assessment,neoplasms

                Comments

                Comment on this article